A College of Pharmacy research team, led by Dan Malone, PhD, professor in the college's Department of Pharmacy Practice and Science, recently traveled to Washington, D.C. to present consensus recommendations of three expert panels to improve the value of drug-drug interaction (DDI) alerts in clinical decision support (CDS). The open four-hour forum was part of the dissemination phase of an Agency for Healthcare Research and Quality (AHRQ)-funded conference series which convened three workgroups focusing on improvements in the evidence, content and usability of DDI alerting systems. The forum was held prior to the American Medical Informatics Association (AMIA) Annual Symposium.
Leaders of workgroups in each of the three areas presented an overview and recommendations for improving DDI CDS alerts on a national level. The workgroup teams have been developing recommended standards over the past two years.
Jon Duke, MD, MS, Regenstrief Institute, gave the keynote address, followed by presentations from Malone, University of Arizona College of Pharmacy; Rick Scheife, PharmD, Tufts University; Hugh Tilson, MD, DrPH, University of North Carolina; and Tom Payne, MD, University of Washington.
Reactions to proposed consensus recommendations were discussed by those in attendance, providing an opportunity for additional input by a variety of stakeholder groups, including clinicians, pharmacists, government agencies, and knowledgebase and CDS vendors. The research team is currently coordinating the preparation of manuscripts outlining the recommendations in the three workgroup areas. Those expected to directly benefit from this effort include healthcare professionals involved in the medication process, and drug compendia and knowledge-base editors.
The next phase in the dissemination process includes two presentation sessions at the American Society of Health System Pharmacists (AHSP) Midyear Clinical Meeting and Exhibition in December.
For full details about this project, click here.
Funding for this conference was made possible [in part] by No. 1R13HS021826-01 from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
DDI Conference Series research team: (left to right) Sheila Gephart, PhD, RN; Mary Brown, PhD, Lynne Mascarella, MEd; Lisa Hines, PharmD; Dan Malone, PhD; Amy Grizzle, PharmD; and Loretta Peters, BA.
Jon Duke, MD, MS, from the Regenstrief Institute, gave the keynote address at the forum.